Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOBR Safe, Inc. Director's Dealing 2019

Sep 18, 2019

35413_dirs_2019-09-18_7b1e3bea-fa9e-4575-9cce-a88cb3172f3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransBiotec, Inc. (IMLE)
CIK: 0001425627
Period of Report: 2019-08-28

Reporting Person: Mishal Devadatt M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-08-28 Common Stock P 13134420 $0.0041 Acquired 20534857 Direct

Footnotes

F1: The Reporting Person acquired 13,134,420 shares of the Issuer's common stock in exchange for a $54,478.01 reduction in the amount the Issuer owes the Reporting Person under certain promissory notes. The transaction was documented with a Stock Purchase Agreement and was completed in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.